Skip to main content
NY Home homeNews home
Story

Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo - Investor's Business Daily

Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo  Investor's Business Daily Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk - WSJ  The Wall Street Journal Pfizer plays hardball in weight-loss drug fight  Financial Times Novo Nordisk says Metsera bid won't raise antitrust issues  Reuters Novo Nordisk Stock: Desperate Move (NYSE:NVO)  Seeking Alpha

Latest News